The American Journal of Hypertension is a monthly, peer-reviewed journal that provides a forum for scientific inquiry of the highest standards in the field of hypertension and related cardiovascular disease. The journal publishes high-quality original research and review articles on basic sciences, molecular biology, clinical and experimental hypertension, cardiology, epidemiology, pediatric hypertension, endocrinology, neurophysiology, and nephrology.

The journal is well-regarded, with a Journal Impact Factor™ of 3.2 and a current ranking of 29 of 67 by Impact Factor in the Peripheral Vascular Disease category of the 2022 JCR Science Edition. 

Editor-in-Chief:
Ernesto L. Schiffrin, C.M., MD, PhD, FRSC, FRCPC, FACP
A native of Argentina who has lived in Canada since 1976, Dr. Ernesto Schiffrin is Physician-in-Chief of the Sir Mortimer B. Davis-Jewish General Hospital and holds a tier 1 Canada Research Chair in Hypertension and Vascular Research at the Lady Davis Institute of Medical Research, and is Professor and Vice-Chair (Research), Department of Medicine, McGill University, all since January 2006. Previously, Dr. Schiffrin was Professor of Medicine at the University of Montreal and Director of the Medical Research Council/Canadian Institutes of Health Research Hypertension Group and the Hypertension Clinic at the Clinical Research Institute of Montreal, and attending physician in the Division of Internal Medicine at Hôtel-Dieu Hospital of the U. of Montreal Hospital Center. He is an American Society of Hypertension certified specialist in hypertension.
Dr. Schiffrin’s research deals with molecular and cellular mechanisms of vascular disease and hypertension and their treatment, supported currently by a Foundation Grant from the Canadian Institutes for Health Research (2015-2022) and an Industry discovery grant. He is author of 530 peer-reviewed publications, many book chapters and is editor of 3 published books, and 1 in press, on molecular and clinical aspects of vascular disease and hypertension. Dr. Schiffrin was Associate Editor of Hypertension (AHA journal) since 2003 to September 15, 2015.
Dr. Schiffrin has been President of the Canadian Hypertension Society (1991-92), Chair of the High Blood Pressure Research Council of the American Heart Association (AHA) (2002-2004), President of the InterAmerican Society of Hypertension (2005-2007), President of the Quebec Hypertension Society (2009-2011), President of the International Society of Hypertension (2012-2014) is now its Immediate Past President. He is President of Hypertension Canada (2013-2016).

Dr. Schiffrin has received numerous awards, including the 2007 Irvine Page-Alva Bradley Lifetime Achievement Award of the AHA High Blood Pressure Research Council, the 2010 Bjorn Folkow Award of the European Society of Hypertension, the 2011 AHA High Blood Pressure Research Council Excellence Award in Hypertension Research, the 2013 American Society of Hypertension Robert Tigerstedt Award, the 2013 Research Achievement Award of the Canadian Cardiovascular Society and the 2015 Distinguished Scientist Award of the Canadian Society of Clinical Investigation. He was appointed Member of the Order of Canada (C.M.) in July 2010.
Associate Editors:
David A. Calhoun, MD
Dr. David Calhoun is a Professor of Medicine, Vascular Biology and Hypertension Program and Center for Sleep/Wake Disorders at The University of Alabama at Birmingham. He earned undergraduate and medical degrees from the University of Virginia, Charlottesville, Virginia. After completing his medical residency at the University of Alabama at Birmingham, he did a post-doctoral research fellowship in vascular biology under the tutelage of Dr. Suzanne Oparil. He currently has joint faculty appointments in the UAB Hypertension Program and in the Center for Sleep/Wake Disorders. Dr. Calhoun is an active clinical investigator. He has an extensive bibliography in clinical hypertension, including over 150 peer-reviewed journal articles and book chapters. His major research focus has been defining causes of resistant hypertension and identification of novel treatment strategies for resistant hypertension. In that regard, Dr. Calhoun has made important contributions defining aldosteronism as common cause of resistant hypertension, demonstrating that mineralocorticoid receptor antagonists, such as spironolactone, provide substantial add-on benefit for treatment of resistant hypertension, and in identifying the critical role of excess dietary sodium in causing antihypertensive treatment resistance.
Currently, his laboratory is evaluating a proposed phenotype of refractory hypertension or antihypertensive failure that preliminary data suggests is attributable to sympathetic hyperactivity.
John M. Flack, MD, MPH
Dr. John M. Flack is Professor and Chair of the Department of Internal Medicine at Southern Illinois University School of Medicine in Springfield. Dr. Flack is a renowned hypertension specialist and sees patients with complex hypertension and related conditions in a hypertension clinic.
Prior to joining Southern Illinois University in May 2015, Flack held numerous positions at Wayne State University School of Medicine in Detroit, including Chair of Wayne State’s Internal Medicine Department for eight years. He served as the founding director of the Division of Translational Research and Clinical Epidemiology (TRaCE) and was principal investigator of the National Institute of Environmental Health Sciences (NIEHS)-funded Center for Urban Health.
Flack is board certified in Internal Medicine and an American Society of Hypertension (ASH) certified specialist in clinical hypertension. He serves as the Vice President of the ASH Hypertension Specialist Board.
He completed an NIH post-doctoral fellowship in cardiovascular epidemiology at the University of Minnesota (1990); he also completed a year as Chief Medical Resident (1985-’86), an Internal Medicine residency (1982-’85) and his medical degree from the University of Oklahoma Health Sciences Center (1982). He received a bachelor’s degree in chemistry from Langston University (1978).
His research interests are in clinical trial design, hypertension in African-Americans, the vascular and hemodynamic determinants of resistant hypertension and the effects of Vitamin D on blood pressure and body composition.
Sadayoshi Ito, MD, PhD
Prof. Sadayoshi Ito is currently Executive Vice President, Research and Scientific Affairs, at Tohoku University, Sendai, Japan. He is also Professor and Chair of Division of Nephrology, Endocrinology and Hypertension at the same university since 1997. Prof. Ito received his MD in 1979, and Ph.D. in 1986, from Tohoku University School of Medicine. Following clinical training, he was a Fellow (1982-84) and a Senior Staff Investigator (1987-95) at Henry Ford Hospital in the USA. Prof. Ito has developed unique technologies for isolation and perfusion of a single glomerular afferent or efferent arteriole, and for simultaneous perfusion of both an arteriole and the attached macula densa. He has published over 400 original scientific papers in English. For his scientific achievements, Prof. Ito has received many awards and prizes, including Arthur C. Corcoran Memorial Lecture Award (American Heart Association) and Robert Tigerstedt Award (American Society of Hypertension). Dr. Ito has been playing important roles in many national and international societies, such as Council member of International Society of Nephrology. He served as a Chief Editor of Nephron from 1999 to 2002, and fills or has filled an important role in journals like Journal of American Society of Nephrology and Hypertension Research.
R. Clinton Webb, PhD
Dr. R. Clinton Webb is the Chair of the Department of Physiology, Augusta University. His research interests include the physiology of vascular smooth muscle with particular emphasis placed on hypertension, diabetes and sexual dysfunction.
Dr. Webb is a fellow of the American Heart Association’s Council for Hypertension and a member of the American Society of Hypertension, the American Physiological Society (APS) and the American Society for Pharmacology and Experimental Therapeutics. He was the inaugural recipient of the Bodil M. Schmidt-Nielsen Distinguished Mentor and Scientist Award, APS’s Women in Physiology Committee in 2004. He received the Carl J. Wiggers Award from the APS in 2012 and the AstraZeneca Award from the International Society for Hypertension in 2012. In 2013, he received the Irvine Page and Alva Bradley Lifetime Achievement Award from the AHA Council for Hypertension.
Dr. Webb earned a B.A. in Physiology in 1971 from Southern Illinois University and a Ph.D. (Anatomy) from the University of Iowa in 1976. He completed postdoctoral fellowships in the Department of Physiology, University of Michigan (1976-78) and the Department of Pharmacology, Universitaire Instelling Antwerpen in Antwerp, Belgium (1978-79).
As a mentor for nearly four decades, Dr. Webb has promoted the careers of many students and postdoctoral fellows. Forty-two postdoctoral fellows have trained in his laboratory and he has served as the thesis supervisor for twenty-two graduate students.
Managing Editor:
Yvonne P. Raiford
Founding Editor-In-Chief:
John H. Laragh, MD
Emeritus Editor-In-Chief:
Michael H. Alderman, MD
Guest Editors:
Theodore A. Kotchen, MD
Charles T. Stier, Jr., PhD
Editorial Board:
Rajiv Agarwal, Indianapolis, Indiana
Amy C. Arnold, Nashville, Tennessee
Leonelo Bautista, Madison, Wisconsin
Sahul Bharti, Chandigarh, India
Italo Biaggioni, Nashville, Tennessee
Ana M. Briones, Madrid, Spain
Nancy J. Brown, Nashville, Tennessee
Vito M. Campese, Los Angeles, California
Bernard Cheung, Pokfulam, Hong Kong
John Cockcroft, Cardiff, United Kingdom
Marcelo Correia, Rio de Janeiro, Brazil
Allen W. Cowley, Jr., Milwaukee, Wisconsin
Cesare Cuspidi, Monza, Italy
Peter de Leeuw, Maastricht, The Netherlands
Giovanni de Simone, Naples, Italy
Shripad B. Deshpande, Varanasi, India
Bin Dong, Bejing, China
Brent M. Egan, Greenville, South Carolina
Satoru Eguchi, Philadelphia, Pennsylvania
Adviye Ergul, Augusta, Georgia
Keith C. Ferdinand, New Orleans, Louisiana
Toshiro Fujita, Tokyo, Japan
John Funder, Clayton Victoria, Australia
Rayna J. Gonzales, Phoenix, Arizona
Stella Goulopoulou, Fort Worth, Texas
Joey P. Granger, Jackson, Mississippi
Guido Grassi, Monza, Italy
Pavel Hamet, Montreal, Quebec, Canada
Stephen B. Harrap, Parkville, Victoria, N.S.W., Australia
Ramon Hermida, Vigo, Pontevedra, Spain
Kenneth A. Jamerson, Ann Arbor, Michigan
Kazuomi Kario, Tochigi, Japan
Lawrence R. Krakoff, New York, New York
Daniel T. Lackland, Charleston, South Carolina
Frans Leenen, Ottawa, Canada
Virginia Soares Lemos, Belo Horizante, Brazil
Phillip D. Levy, Detroit, Michigan
Gregory Y.H. Lip, Liverpool, United Kingdom
Alexander G. Logan, Toronto, Ontario, Canada
Giuseppe Mancia, Milan, Italy
David A. McCarron, Portland, Oregon
Brett Mitchell, Temple, Texas
Trefor O. Morgan, Parkville, Victoria, N.S.W, Australia
Alberto Morganti, Milan, Italy
L. Gabriel Navar, New Orleans, Louisiana
Shawna D. Nesbitt, Dallas, Texas
Michael F. O'Rourke, Darlinghurst, Australia
Sante D. Pierdomenico, Chieti Scalo, Italy
J. Howard Pratt, Indianapolis, Indiana
Jane Reckelhoff, Jackson, Mississippi
Kristi Reynolds, Pasadena, California
Nancy J. Rusch, Little Rock, Arkansas
Esther Sabban, Valhalla, New York
Michel Safar, Paris Cedex 04, France
Giusseppi Schillaci, Perugia, Italy
Roland E. Schmieder, Nuremberg, Germany
James Sharman, Hobart,TAS, Australia
Kazuaki Shimamoto, Sapporo, Japan
Daichi Shimbo, New York, New York
Domenic Sica, Richmond, Virginia
Alan Sinaiko, Minneapolis, Minnesota
Jan A. Staessen, Leuven, Belgium
George S. Stergiou, Athens, Greece
Jennifer Sullivan, Augusta, Georgia
Rita Tostes, Sao Paulo, Brazil
Paolo Verdecchia, Perugia, Italy
Ji-Guang Wang, Shanghai, China
Thomas Weber, Wels, Austria
Stephanie Watts, East Lansing, Michigan
William B. White, Farmington, Connecticut